⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
accessnewswire.com
JAGX
Necrotizing Enterocolitis Market to Register Stunning Growth at a CAGR of 26% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
JAGX
MRK
CASI
JAZZ
Thomas Murray Publishes Second Report
accessnewswire.com
JAGX
FREELANDER Confirms September Abu Dhabi Brand Launch at Goodwood Festival of Speed, Marking the Next Step in Global Expansion
globenewswire.com
JAGX
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
accessnewswire.com
JAGX
FREELANDER markerar nästa steg i den globala expansionen och bekräftar lanseringen av varumärket i Abu Dhabi i september vid Goodwood Festival of Speed
globenewswire.com
JAGX
FREELANDER تؤكد إطلاق علامتها التجارية في أبوظبي خلال سبتمبر/أيلول في مهرجان غودوود للسرعة، في خطوة جديدة ضمن مسار توسعها العالمي
globenewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Form 8-K
sec.gov
JAGX
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
accessnewswire.com
JAGX